Skip to main content

Table 1 Demographic and baseline characteristics

From: A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand

  ALN* (n = 245) MAS3** (n = 245)
Maela 100 100
Mawker Tai 145 145
Males, no. (%) 172 (70) 164 (67)
Age, years   
Mean (SD) 23.2 (14.6) 23.6 (15.1)
Range 3–70 2–72
Age group, no. (%)   
<5 10 (4.1) 8 (3.3)
5–14 81 (33.1) 75 (30.6)
>14 154 (62.9) 162 (66.1)
Weight, kg   
Mean (SD) 42.4 (14.5) 42.3 (15.0)
Range 10–77 10–78
Temperature, °C   
Mean (SD) 37.7 (1.0) 37.8 (1.1)
Range 35.6–40.5 35.9–41.0
Fevera, no (%) 136 (55.5) 142 (58.0)
Haematocrit, %   
Mean (SD) 36.7 (5.9) 36.4 (5.8)
Range 21–52 20–51
Geometric mean (range) 8,047 7,570
parasite count (μl-1) (32–198,789) (16–198,789)
Hepatomegaly, no (%) 48 (19.6) 50 (20.4)
Splenomegaly, no (%) 70 (28.6) 57 (23.3)
  1. * ALN = artemether-lumefantrine, ** MAS3 = artesunate-mefloquine aTympanic temperature ≥ 37.5°C
\